logo

For the Inventor, By the Inventor

Old Harlow, United Kingdom

Joanne Rachel Evans

This inventor holds 5 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2000-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joanne Rachel Evans. Retrieved from https://idiyas.com/inventor/joanne-rachel-evans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 80.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 43(Granted Patents)


Location History:

  • Herts, GB (2000)
  • Bishops Stortford, GB (2000)
  • Nerts, GB (2001)
  • Old Harlow, GB (2001 - 2002)

Company Filing History:

goldMedal7 out of 2,198 
 
Smithkline Beecham Corporation
 patents
where one patent can have more than one assignee

Years Active: 2000-2002

Loading Chart...
5 patents (USPTO):Explore Patents
1. 6426405 - Neurotransmitter transporter SC6 (2002-07-30),
2. 6255468 - MPROT12 polynucleotides and methods thereof (2001-07-03),
3. 6238883 - Neurotransmitter transporter SC6 (2001-05-29),
4. 6162630 - ASP1 (2000-12-19),
5. 6025180 - ASP1 (2000-02-15),

Title: Unveiling the Innovation Journey of Inventor Joanne Rachel Evans

Introduction:

Joanne Rachel Evans, a prolific inventor hailing from Old Harlow, GB, has left an indelible mark in the field of scientific innovations. With a portfolio of 5 patents to his name, his groundbreaking work continues to revolutionize the landscape of therapy and diagnostic assays.

Latest Patents:

Among his latest patents is the Neurotransmitter transporter SC6, unveiling the complexities of SC6 polypeptides and polynucleotides. These innovative methods not only offer new avenues for therapy but also pave the way for advanced diagnostic assays. Additionally, the MPROT12 polynucleotides mark another milestone in his journey, showcasing the potential for MPROT12 polypeptides in therapeutic applications.

Career Highlights:

Joanne Rachel Evans is a valuable asset to the SmithKline Beecham Corporation, where his inventive spirit thrives. His dedication to pushing the boundaries of science has led to the successful filing of 5 patents, each contributing significantly to the scientific community.

Collaborations:

In his quest for innovation, Joanne Rachel Evans has collaborated with esteemed colleagues such as Conrad Gerald Chapman and Christopher Donald Southan. Their combined efforts have fostered a culture of creativity and excellence, propelling their research endeavors to new heights.

Conclusion:

In conclusion, Joanne Rachel Evans stands as a beacon of innovation, continuously striving to pioneer advancements in therapy and diagnostics. His remarkable journey serves as an inspiration to aspiring inventors and underscores the profound impact of relentless dedication to scientific pursuits.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…